Tag: Safinamide

Affecting nearly 1 million people in the United States, Parkinson's disease can cause debilitating motor fluctuations known as 'off' episodes. For many with mid- to late-stage disease, safinamide is used for management as an add-on treatment to levodopa to help smooth out these symptoms.

According to a 2025 market report, the medication safinamide, marketed under the brand name Equfina in Japan and some other Asian countries, is indicated for Parkinson's disease. This targeted therapy helps manage motor fluctuations in patients already receiving treatment with levodopa/carbidopa.